
Fuad El-Hibri
Fuad El-Hibri serves on the Advisory Board for the Yale Healthcare Conference, a joint effort between the Yale School of Management and the Health Professional Schools at Yale University. The 6th annual healthcare conference was held on April 9, 2010 in New Haven, CT. The conference topic was “Re-Forming Healthcare: Excellence in a Transforming System” and brought together professionals, academics, and students to engage in an instructive conversation about current healthcare issues. The conference addressed the challenges key stakeholders will face in a changing healthcare system and offered information on how to foster continued excellence. Emergent Biosolutions, LLC, led by CEO and Yale School of Management alumnus, Fuad El-Hibri, co-sponsored the conference. For more information, please see http://www.yalehealthcare.com/advisory.php
Mr. Fuad El-Hibri has served as chief executive officer and chairman of the board of directors of Emergent Biosolutions Inc., since June 2004 and as president from March 2006 to April 2007. Mr. El-Hibri served as chief executive officer and chairman of the board of directors of BioPort Corporation from May 1998 until June 2004, when, as a result of corporate reorganization, BioPort became a wholly owned subsidiary of Emergent. Mr. El-Hibri served as chairman of Digicel Holdings, Ltd., a privately held telecommunications firm, from August 2000 to October 2006. Fuad El-Hibri Yale Health Care Advisory Board
Fuad El-Hibri, MBA
Chief Executive Officer and Chairman of the Board of Directors
Emergent Biosolutions, Inc.
Yale School of Management

Mr. El-Hibri has served as chairman of East West Resources Corporation, a venture capital and financial consulting firm, since June 1990. He served as president of East West Resources from September 1990 to January 2004. Mr. El-Hibri is a member of the board of trustees of American University and a member of the board of directors of the International
Biomedical Research Alliance, an academic joint venture among the NIH,
Oxford University and
Cambridge University. He also serves as chairman and treasurer of El-Hibri Charitable Foundation. Mr. El-Hibri received a
master’s degree in public and private management from Yale University and a B.A. in economics from Stanford University.
Categories: BioThrax, Earnings Report, El-Hibri Foundation, El-Hibri Fuad, El-Hibri Peace Education, El-Hibri Peace Education Prize, Emergent BioSolutions, Entrepreneur of the Year, Ernst & Young, FDA, Food and Drug Administration, Fuad El-Hibri, Fuad Elhibri, Hepatitis B Vaccine, Hepatitis Vaccine, Islam, Shareholders, Uncategorized, W. James Jackson, Washington DC, Washington Gala, Yale Health Care, Yale School of Management, Yale University Tags: Board of directors, Chief executive officer, Emergent BioSolutions, Stanford University, Subsidiary, United States, Yale School of Management, Yale University
Recent Comments